An internal standard for the quantification of guanfacine
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Guanfacine-13C,15N3

Item No. 30143

Technical Information
Formal Name
N-(amino-15N-imino-15N-methyl-13C)-2,6-dichloro-benzeneacetamide-15N
CAS Number
1189924-28-4
Molecular Formula
C8[13C]H9Cl2[15N]3O
Formula Weight
Purity
≥95%
Formulation
A solid
Methanol: slightly, sonicated
SMILES
ClC1=C(CC([15NH][13C]([15NH2])=[15NH])=O)C(Cl)=CC=C1
InChi Code
InChI=1S/C9H9Cl2N3O/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13/h1-3H,4H2,(H4,12,13,14,15)/i9+1,12+1,13+1,14+1
InChi Key
INJOMKTZOLKMBF-DATIIYMNSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Guanfacine-13C,15N3 is intended for us as an internal standard for the quantification of guanfacine (Item No. 22907) by GC- or LC-MS. Guanfacine is an α2-adrenergic receptor (α2-AR) agonist with Ki values of 93, 1,380, and 3,890 nM for α2A-, α2B-, and α2C-ARs, respectively, in a radioligand binding assay.1 It has EC50 values of 52, 288, and 602 nM for α2A-, α2B-, and α2C-ARs, respectively, for stimulated [35S]GTPγS binding. It also binds to imidazoline receptor 1 (Ki = 19 nM in a radioligand binding assay).2 Guanfacine (0.3-5 mg/kg) binds to adrenergic receptors in the central nervous system and lowers blood pressure in hypertensive rats in a dose-dependent manner.3 It also improves spatial working memory deficits induced by hypobaric hypoxia in rats.4 Formulations containing guanfacine are used in the treatment of high blood pressure and attention deficit hyperactivity disorder (ADHD).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Jasper, J.R., Lesnick, J.D., Chang, L.K., et alLigand efficacy and potency at recombinant α2 adrenergic receptors: Agonist-mediated [35S]GTPγS binding. Biochem. Pharmacol. 55(7), 1035-1043 (1998).

    2. Nikolic, K., Filipic, S., and Agbaba, D. QSAR study of imidazoline antihypertensive drugs. Bioorg. Med. Chem. 16(15), 7134-7140 (2008).

    3. Scholtysik, G. Pharmacology of guanfacine. Br. J. Clin. Pharmacol. 10(Suppl 1), 21S-24S (1980).

    4. Kauser, H., Sahu, S., Kumar, S., et alGuanfacine is an effective countermeasure for hypobaric hypoxia-induced cognitive decline. Neuroscience 254, 110-119 (2013).